Moreover, we further used BAY 11-7082, an NF-κB Inhibitor, to suppress the NF-κB activity in HD cells after IGF2 treatment, and examined the mHTT aggregates via Western blotting. The gene discussed is IGF2; the disease is Huntington disease.